MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Viking Therapeutics, Inc

VKTX

#1306
Viking Therapeutics, Inc. - Common Stock
32.7 4 USD
+1.71%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
32.74
32.74
Year Range
22.95
43.15
Daily Change
+1.71%
Monthly Change
+7.41%
6 month change
-9.41%
Year Change
+18.11%
Previous Close
32.1 9
Open
32.7 4
Low
32.7 4
High
32.7 4
Volume
121
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. VKTX
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 3.8 B
  • Employee 59
  • Founded 2012
  • CEO Brian Lian
  • Website www.vikingtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG006LGV869
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

News

Zacks Zacks
VKTX
yesterday, 15:30
Why Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?
Zacks Zacks
NVO LLY VKTX GPCR
yesterday, 14:49
LLY Stock Gains 4% to All-Time High: Is Obesity Access the Catalyst?
Zacks Zacks
VKTX
2 days ago, 21:45
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.26
Can EU Label Expansions of NVO's GLP-1 Drugs Spur Sales Growth?
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.22
LLY Reports Third Phase III Win for Next-Generation Obesity Drug
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.21
Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story?
Barchart Barchart
VKTX NVO LLY
2026.05.14
This Hot Weight-Loss Drug Stock May Have a Surprise Challenger
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.14
Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.13
Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.11
NVO Rallies 21% in a Month: How Should Investors Play the Stock?
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.06
LLY Stock Pops 16% After Beat-and-Raise Q1: Buy, Hold or Take Profits?
Zacks Zacks
NVO LLY VKTX GPCR
2026.05.05
Lilly's Oral GLP-1 Pill Foundayo Starts Strong in Oral Obesity Market

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd